234 related articles for article (PubMed ID: 23056557)
1. Optical biomarkers of serous and mucinous human ovarian tumor assessed with nonlinear optics microscopies.
Adur J; Pelegati VB; de Thomaz AA; Baratti MO; Almeida DB; Andrade LA; Bottcher-Luiz F; Carvalho HF; Cesar CL
PLoS One; 2012; 7(10):e47007. PubMed ID: 23056557
[TBL] [Abstract][Full Text] [Related]
2. Quantitative changes in human epithelial cancers and osteogenesis imperfecta disease detected using nonlinear multicontrast microscopy.
Adur J; Pelegati VB; de Thomaz AA; D'Souza-Li L; Assunção Mdo C; Bottcher-Luiz F; Andrade LA; Cesar CL
J Biomed Opt; 2012 Aug; 17(8):081407-1. PubMed ID: 23224168
[TBL] [Abstract][Full Text] [Related]
3. Recognition of serous ovarian tumors in human samples by multimodal nonlinear optical microscopy.
Adur J; Pelegati VB; Costa LF; Pietro L; de Thomaz AA; Almeida DB; Bottcher-Luiz F; Andrade LA; Cesar CL
J Biomed Opt; 2011 Sep; 16(9):096017. PubMed ID: 21950931
[TBL] [Abstract][Full Text] [Related]
4. Harmonic optical microscopy and fluorescence lifetime imaging platform for multimodal imaging.
Pelegati VB; Adur J; De Thomaz AA; Almeida DB; Baratti MO; Andrade LA; Bottcher-Luiz F; Cesar CL
Microsc Res Tech; 2012 Oct; 75(10):1383-94. PubMed ID: 22648907
[TBL] [Abstract][Full Text] [Related]
5. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
Saied EM; El-Etreby NM
Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.
Ye F; Hu Y; Zhou C; Hu Y; Chen H
Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance].
Zhang LL; Shao SL; Wu Y
Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306
[TBL] [Abstract][Full Text] [Related]
8. Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.
Elias KM; Labidi-Galy SI; Vitonis AF; Hornick JL; Doyle LA; Hirsch MS; Cramer DW; Drapkin R
Gynecol Oncol; 2014 Feb; 132(2):328-33. PubMed ID: 24342438
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer.
Oktem G; Sanci M; Bilir A; Yildirim Y; Kececi SD; Ayla S; Inan S
Int J Gynecol Cancer; 2012 Jan; 22(1):23-9. PubMed ID: 22080880
[TBL] [Abstract][Full Text] [Related]
10. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
11. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases].
Giurgea NL; Pitrop M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925
[TBL] [Abstract][Full Text] [Related]
12. Second harmonic generation microscopy as a powerful diagnostic imaging modality for human ovarian cancer.
Adur J; Pelegati VB; de Thomaz AA; Baratti MO; Andrade LA; Carvalho HF; Bottcher-Luiz F; Cesar CL
J Biophotonics; 2014 Jan; 7(1-2):37-48. PubMed ID: 23024013
[TBL] [Abstract][Full Text] [Related]
13. Alteration of BRCA-1 tumor suppressor gene expression in serous and mucinous ovarian neoplasms in the benign-borderline-malignant pathway.
Yousif HMA; Mohammed RAA
Curr Probl Cancer; 2019 Aug; 43(4):377-385. PubMed ID: 30446260
[TBL] [Abstract][Full Text] [Related]
14. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement.
Tang S; Yang F; Du X; Lu Y; Zhang L; Zhou X
Int J Gynecol Pathol; 2016 Jul; 35(4):337-47. PubMed ID: 27271776
[TBL] [Abstract][Full Text] [Related]
16. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363
[TBL] [Abstract][Full Text] [Related]
17. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
[TBL] [Abstract][Full Text] [Related]
18. Expression of Sox2 in human ovarian epithelial carcinoma.
Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
J Cancer Res Clin Oncol; 2011 Jan; 137(1):131-7. PubMed ID: 20349085
[TBL] [Abstract][Full Text] [Related]
19. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival.
Kwon AY; Heo I; Lee HJ; Kim G; Kang H; Heo JH; Kim TH; An HJ
Virchows Arch; 2016 May; 468(5):597-605. PubMed ID: 26951260
[TBL] [Abstract][Full Text] [Related]
20. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
